Medicare Advantage vs. Original Medicare
Medicare is the federal health insurance program for people who are 65 or older, certain younger people with disabilities, and
Read More
Part D/Prescription Drugs
Boost Now or Wait? Many Wonder How Best to Ride Out Covid’s Next Wave
(By Sam Whitehead and Arthur Allen for Kaiser Health News) Gwyneth Paige didn’t want to get vaccinated against covid-19 at
Read MorePaying entire out-of-pocket cost for generic drugs
Researchers from Avalere Heath, using current CMS prescription drug event data, found more than half of the Medicare beneficiaries who
Read MoreAs Big Pharma Loses Interest in New Antibiotics, Infections Are Only Growing Stronger
(By Arthur Allen for Kaiser Health News) Forget covid-19, monkeypox, and other viruses for the moment and consider another threat
Read MoreFDA rule would facilitate prescription-to-OTC switches but nix a third class of drugs
(By Martha Rumore for STAT) After a decade-long wait, the Food and Drug Administration finally issued a proposed rule in
Read MoreMedicare Advantage patients less likely to get pricier diabetes meds, study finds
(By Andrew Cass for Becker’s Hospital Review) Diabetes patients’ Medicare Advantage plans were more likely to receive preventive treatments than
Read MoreStrengthening Behavioral Health Care for People with Medicare
(Source – www.cms.gov/blog) COVID-19 has exacerbated the nation’s struggle with mental health and substance use disorders (collectively called “behavioral health
Read MoreSenate Democrats advance plan to give Medicare drug price negotiation powers: 6 notes
(By Jakob Emerson for Becker’s Hospital Review) U.S. Senate Democrats reached a legislative agreement June 6 that would allow Medicare
Read MoreSeeking to Kick-Start Biden’s Agenda, Schumer Unveils a Bill for Medicare Drug Price Negotiations
(By Michael McAuliff for Kaiser Health News) Democratic senators on Wednesday took a formal step toward reviving President Joe Biden’s
Read MoreCMS rule limiting 3rd-party Medicare Advantage, Part D marketing now in effect
(By Jakob Emerson for Becker’s Hospital Review) A CMS rule revising Medicare Advantage and Part D marketing and communication regulations
Read More